These side effects typically diminish as the body adjusts, but understanding what to expect helps patients prepare rather than panic
Not all patients respond equally to GLP-1 agonist therapy, and identifying optimal candidates requires considering multiple factors, including baseline weight, comorbidities, and individual tolerance profiles
rigidity, i.e
The retatrutide versus tirzepatide debate involves fundamentally different mechanisms, different risk profiles, different timelines for access, and different metabolic benefits that extend well beyond body weight
Sperm parameter improvement does not always translate to increased conception rates in all men with infertility, so it's worth keeping your expectations realistic as you weigh your options
Do You Really Need a Dedicated GLP-1 Travel Case